Skip to main content

Table 3 Genotype distribution across mammographic density Vermont cohort

From: A germline mutation in the BRCA13’UTR predicts Stage IV breast cancer

Mammographic density <50% rs8176318 positive rs8176318 negative p-value*
Full cohort 93 70 0.2948
Pre-menopausal 49 39 0.7842
Post-menopausal 35 28 0.2530
Normal BMI 26 22 0.7342
Overweight BMI 29 20 0.3115
Obese BMI 36 26 0.0398
Menarche age 7-11 16 17 0.7848
Menarche age 12-13 48 33 0.4672
Menarche age ≥14 18 9 0.2123
  1. *P-values represent significance of the association between mammographic density and the presence or absence of rs8176318.